Nationwide News says two expert reports written by a friend and agent of actor Geoffrey Rush should be thrown out because the two are advocates for Rush, as the first week in the closely watched defamation trial wrapped up.
The director of the King Lear production at the centre of a defamation case brought by Geoffrey Rush said on the witness stand Thursday he never told the actor his behaviour toward co-star Eyrn Jean Norvill had become “creepy”.
Geoffrey Rush was cross-examined at length on Tuesday about the meaning behind a text he sent to colleague Eryn Jean Norvill that included an emoji with its tongue sticking out, during the second day of trial in the defamation case against Nationwide News.
Liquidators for the collapsed Hastie Group will pursue test cases against two construction companies in their legal fight against more than two dozen major builders over tens of millions of dollars in unpaid bills, but an application is looming to halt the proceedings pending the outcome of a High Court challenge.
Oscar-winning actor Geoffrey Rush has told a court he endured “the worst 11 months” of his life following the publication of two Daily Telegraph articles that accused him of inappropriate behaviour toward his co-star during a 2015 production of King Lear.
AFT Pharmaceuticals breached the consumer laws with misleading ads over the strength of its painkiller Maxigesic, a judge has found, siding with rival drug maker Reckitt Benckiser.
A director of a corporate advisory firm has been ordered to name names in his defence of a lawsuit brought by Mineral Resources over tweets suggesting the lithium mining company’s ore has a bad reputation in China.
A Federal Court judge has ordered three individuals targeted in an ASIC lawsuit over binary option trading to pay $60,000 in contempt of court penalties for breaching court-imposed freezing orders.
An investor suing property investment group Aviation 3030 can’t avoid payment of half a million dollars in security for litigation costs because of a parallel enforcement action by the corporate regulator, a judge has ruled.
Consumer goods giant Reckitt Benckiser has been permanently barred from displaying select ads for its Strepfen throat lozenges, as the Federal Court dismissed proceedings filed by rival iNova Pharmaceuticals.